Russia has proposed full-cycle technology transfer and licensed production of its combat-proven Lancet-3 loitering munition to India, announced by Rostec CEO Sergey Chemezov during President Vladimir Putin’s state visit on December 4-5, 2025. Key dates include the offer following the India-Russia summit in New Delhi, where bilateral talks emphasized defense indigenization amid ‘Make in India’. The Lancet-3, with over 80% hit probability against moving targets demonstrated in Ukraine, bolsters India’s precision strike needs along the LAC with China. Actors involved: Rostec, Hindustan Aeronautics Limited (HAL) Nashik for potential production hub, and Indian armed forces seeking self-reliance. Geopolitically, this counters Chinese drone superiority, fortifies India-Russia ties against Western sanctions, and positions India as a munitions exporter, enhancing strategic autonomy in contested borders.